A standard blood test ordered by your doctor, such as a complete blood count or a basic metabolic panel, does not screen for cannabis. These routine panels measure things like cholesterol, blood sugar, liver enzymes, and cell counts. They are not designed to detect THC or any other drug. Cannabis only shows up in blood when a test specifically targeting cannabinoids is ordered, which involves a different laboratory process entirely.
What a “Regular” Blood Test Actually Measures
When people worry about weed showing up in bloodwork, they are usually picturing the vials drawn at an annual physical or before a surgery. Those samples go through panels that look at metabolic health markers, organ function, and blood cell composition. The instruments used for these tests are tuned to detect glucose, electrolytes, hemoglobin, and similar compounds. THC and its breakdown products are invisible to that equipment because the assays simply are not looking for them. A lab technician processing your cholesterol panel would have no way of knowing whether you had smoked cannabis the night before, even if THC were circulating in your blood at that moment.
The distinction matters because many people avoid disclosing cannabis use to their doctors out of fear it will appear on routine labs. It will not. A healthcare provider would need to specifically order a drug screen, and in most clinical settings, that requires a reason and often your knowledge. Pre-employment drug testing, legal proceedings, substance-abuse treatment programs, and certain emergency-department protocols are the main situations where a cannabinoid-specific blood test enters the picture.
How a Cannabis-Specific Blood Test Works
When someone does order a test designed to find cannabis in blood, the process typically unfolds in two stages. The first is a screening step using an immunoassay, which is a fast, relatively inexpensive method that flags samples likely to contain cannabinoids. One common version uses an enzyme-linked immunosorbent assay, or ELISA, with a cutoff around 5 ng/mL for THC-COOH, the main inactive metabolite of THC.1Journal of Analytical Toxicology. Evaluation of the Canadian approved drug screening equipment cut-off levels for tetrahydrocannabinol (THC) If the sample screens positive, it moves to a confirmation step using a far more precise technique, usually liquid chromatography paired with tandem mass spectrometry. This second analysis can separately identify and measure THC itself, its active metabolite 11-OH-THC, and the inactive metabolite THC-COOH in whole blood.2PubMed. Qualitative and quantitative analysis of THC, 11-hydroxy-THC and 11-nor-9-carboxy-THC in whole blood by ultra-performance liquid chromatography/tandem mass spectrometry
The screening step is where false positives sometimes occur, and the confirmation step is where the lab pins down exactly what is present and how much. If only the screening step is run, there is room for ambiguity. If both steps are completed, the result is highly specific.
How Long THC Stays in Blood
THC behaves differently in blood than in urine. After you smoke or inhale cannabis, THC surges into the bloodstream within minutes and peaks quickly, then drops sharply as the compound redistributes into fat tissue and organs. For someone who uses cannabis only occasionally, active THC in blood may fall below detectable levels within a few hours. But THC-COOH, the metabolite that lingers much longer, tells a different story. Because THC-COOH has a long half-life and accumulates with repeated use, it can remain detectable in blood for days or even weeks in frequent consumers.
Research on blood-based cannabis detection has found that a THC-COOH concentration above 75 ng/mL is generally associated with regular cannabis use, while levels below 5 ng/mL point toward occasional consumption.3Therapeutic Drug Monitoring. Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use This means a blood test can sometimes distinguish between a person who smoked once at a party last week and someone who uses cannabis daily, at least when the metabolite is measured alongside the parent compound.
For practical purposes, if you are an infrequent user and a cannabis-specific blood test is drawn more than a day or two after your last use, THC itself is unlikely to be detected. If you are a heavy, daily user, both THC and THC-COOH could show up for considerably longer.
Why Blood THC Levels Do Not Map Neatly onto Impairment
One of the most contentious issues in cannabis testing is the assumption that a certain blood THC level means a person is impaired. Several jurisdictions have set legal “per se” limits, often at 5 ng/mL of THC in blood, above which a driver is presumed to be under the influence. The science, however, does not support a clean threshold.
A study examining blood from 30 subjects found that 16 of them still had THC concentrations above 5 ng/mL after a full 12 hours of abstinence, with no measurable impairment at that point.4PubMed Central. Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath This disconnect exists because THC accumulates in fat tissue with regular use and slowly leaks back into the bloodstream. A chronic user can have a resting blood THC level that exceeds the legal cutoff even when completely sober. The researchers concluded that single measurements of THC in blood do not correlate with impairment following inhalation, and that other cannabinoids might be better indicators of recent use.
This creates a real problem for anyone subject to roadside or workplace blood testing. A positive result can carry serious legal consequences, yet the number on the lab report may reflect cannabis consumed days earlier rather than anything that is currently affecting your brain. Forensic guidelines acknowledge this complexity, recommending that toxicology results be interpreted alongside officer observations of behavior, not treated as standalone proof of impairment.5PubMed. Recommendations for toxicological investigation of drug impaired driving
The Fat-Storage Problem
THC is highly fat-soluble, which is why it lingers in the body far longer than alcohol or most other recreational substances. After entering the bloodstream, much of it gets tucked away in adipose (fat) tissue, where it can sit for weeks. What makes this especially tricky is that anything that breaks down fat can push stored THC back into circulation.
Animal research has demonstrated that both food deprivation and stress-hormone exposure promote lipolysis, the process of breaking down fat for energy, and that this lipolysis raises blood levels of THC and THC-COOH in subjects who had previously been exposed to the drug.6PubMed Central. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure The researchers called this phenomenon “reintoxication,” though whether the re-released THC reaches concentrations high enough to cause noticeable psychoactive effects in humans remains uncertain.
The practical takeaway is that for heavy, long-term users, activities like fasting, intense exercise, or periods of high stress could temporarily bump up blood THC levels even without any new cannabis exposure. If a blood test happens to fall during one of those windows, the result may look like recent use when it is really the body clearing old stores.
Can Secondhand Cannabis Smoke Trigger a Positive Blood Test?
This is a question people raise often, and the answer is technically yes, but the conditions required are extreme. Researchers placed nonsmokers in a sealed, unventilated room with active cannabis smokers for one hour and found that THC became detectable in the nonsmokers’ blood for up to three hours afterward.7Journal of Analytical Toxicology. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects The concentrations were low and short-lived, but they were above the limit of quantitation for the lab assay used.
When even minimal ventilation was added to the room, the effect largely disappeared. Under those extreme, unventilated conditions, secondhand cannabis smoke produced detectable THC in blood and urine, along with minor subjective effects and slight impairment on a psychomotor task.8Drug and Alcohol Dependence. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects In everyday life, being around someone smoking a joint at an outdoor gathering, or even in a moderately ventilated room, is very unlikely to produce a positive blood result. The “hotbox” scenario in the study, where thick smoke fills a small sealed space for an extended period, is not something most people experience accidentally.
Delta-8 THC and Other Cannabinoid Variants
The explosion of legal hemp-derived cannabinoids like delta-8 THC has added a new wrinkle to cannabis blood testing. Standard immunoassay screening kits are designed to detect delta-9 THC and its metabolites, but structurally similar compounds can trigger the same antibody response, producing a positive screen.
Research testing the cross-reactivity of various cannabinoid compounds with a standard ELISA kit found that delta-8-carboxy-THC showed roughly double the cross-reactivity of its delta-9 counterpart.9Journal of Analytical Toxicology. Determination of Cross-Reactivity of Contemporary Cannabinoids with THC Direct Immunoassay (ELISA) in Whole Blood This means that using delta-8 products can easily cause a positive screening result, and if the confirmation assay only looks for traditional delta-9 compounds, the lab may return an inconclusive or “unreportable” confirmation. You could end up flagged as positive on the screen with no clear confirmation either way, which is an awkward position in a legal or employment context.
Other emerging cannabinoids structurally close to delta-9 THC also cross-react to varying degrees, with similarity to the delta-9 structure predicting more cross-reactivity. If you use any hemp-derived THC variant and face a blood test, you should expect the screening step to treat you the same as a delta-9 cannabis user.
When Hospitals Draw Blood for Drugs
Emergency departments sometimes order drug screens on patients who arrive with altered mental status, unexplained symptoms, or after a motor vehicle accident. These screens are clinically motivated: the doctors need to know what substances are on board to make safe treatment decisions, not to report you to anyone. In most hospitals, the results are part of your medical record and are protected by privacy laws. They are not automatically shared with employers or law enforcement unless a specific legal process compels it.
That said, the type of drug screen used in emergency settings is usually a urine immunoassay, not a blood test. Urine is faster to collect and cheaper to process, and it has a longer detection window for most substances, making it more useful for a broad clinical picture. Blood-based drug testing in hospitals is less common and tends to be reserved for situations where the timing of drug exposure matters, such as determining whether someone was acutely intoxicated at the time of a crash.
If you are heading into surgery and worried about preoperative bloodwork catching cannabis, the same principle from routine physicals applies: standard pre-surgical panels test organ function and coagulation, not drugs. A separate drug screen would have to be specifically ordered. Some anesthesiologists do want to know about cannabis use because it can affect how the body responds to certain medications, so disclosing use voluntarily is generally in your interest even though the labs will not reveal it on their own.
Sample Handling and Why It Matters
For anyone in a legal or forensic context, the way a blood sample is stored between collection and analysis can affect the result. THC and its metabolites are not perfectly stable in stored blood. Factors like temperature, the type of collection tube, exposure to light, and the length of time before analysis can cause cannabinoid concentrations to degrade or shift. Research reviewing the effects of different storage conditions on cannabis compound stability in biological samples has highlighted this as a critical issue in forensic toxicology.10PubMed Central. Effects of the Storage Conditions on the Stability of Natural and Synthetic Cannabis in Biological Matrices for Forensic Toxicology Analysis: An Update from the Literature
In practice, this means that a blood sample left at room temperature for an extended period may show a lower THC concentration than it would have if tested immediately or stored properly at low temperature. For someone contesting a positive result, this is relevant: the measured concentration might underestimate or, in some degradation pathways, misrepresent what was actually present at the time of collection. Forensic labs follow chain-of-custody protocols to minimize these issues, but the sensitivity of cannabinoids to storage conditions is one more reason that a single number on a lab report is not as simple as it looks.
Situations Where Cannabis Blood Testing Actually Happens
Understanding when you might actually face a cannabis-specific blood draw helps separate reasonable concern from unnecessary anxiety. The most common scenarios include:
- Impaired driving investigations: Many jurisdictions use blood tests as part of a drug-impaired driving case, particularly when a breathalyzer is negative for alcohol but the officer suspects drug use.
- Workplace incidents: Post-accident drug testing in safety-sensitive industries sometimes involves blood rather than urine, especially when the employer wants evidence of recent use rather than use from weeks ago.
- Court-ordered testing: Probation, custody disputes, and substance-abuse treatment programs may require blood-based cannabinoid monitoring.
- Military and federal positions: While urinalysis is the standard for military drug screening, blood may be used in follow-up or confirmation settings.
Routine annual physicals, insurance medical exams, and standard pre-employment health screenings almost never include blood-based cannabis testing. Even dedicated pre-employment drug screens overwhelmingly use urine, not blood. If your worry is about a doctor’s office visit or a general health panel, you can set that concern aside entirely.
CBD Products and Blood Tests
Pure CBD (cannabidiol) does not convert into THC in the body and should not trigger a positive cannabinoid screen. The catch is that many CBD products, particularly full-spectrum oils and hemp flower, contain trace amounts of THC, sometimes more than the label states. Consuming large quantities of a full-spectrum CBD product daily could, in theory, build up enough THC or THC-COOH to produce a positive immunoassay result, especially given the cross-reactivity issues discussed earlier.
If you use CBD products and face regular testing, broad-spectrum or isolate-based products carry less risk than full-spectrum ones, though no product completely eliminates the possibility unless it truly contains zero THC. Certificates of analysis from third-party labs are the closest thing to a guarantee, and even those only reflect the batch tested.
How Blood Compares to Other Testing Methods
Blood is not the most common matrix for cannabis detection in everyday life. Urine testing dominates workplace and clinical settings because it is noninvasive, inexpensive, and catches cannabis use over a wider time window, sometimes weeks for daily users. Oral fluid (saliva) testing is growing in popularity for roadside screening because it is easy to collect on the spot. Hair testing can detect cannabis exposure over months but says little about recent use.
Blood occupies a narrow but important niche: it is the best available tool for estimating how recently cannabis was consumed, because active THC in blood peaks and falls relatively quickly after use. This makes blood the preferred specimen when the question is “was this person recently under the influence?” rather than “has this person used cannabis at some point in the past month?” The tradeoff is that blood collection requires a trained phlebotomist and a controlled environment, making it impractical for mass screening.
For the vast majority of people wondering whether their doctor will find out about their cannabis use from a blood draw, the answer remains no. The tests your doctor orders and the tests that look for THC are entirely different instruments looking for entirely different things. Unless someone specifically requests a cannabinoid screen, your blood panel will have nothing to say about what you smoked last weekend.